Cellapeutics bio logo

Cellapeutics bio

Global standard of cell reprogramming platform

8 employees · est. 2020 · Korea South

VS
GeneMedicine logo

GeneMedicine

Biopharmaceutical company focusing on R&D and commercializing its oncolytic adenovirus platform for cancer treatment.

11 employees · est. 2014 · Seoul, Korea South

GeneMedicine is the older company (2020 vs 2014); GeneMedicine is the larger of the two.

Side-by-Side Comparison

Cellapeutics bio GeneMedicine
Founded
2020 2014 older
Headquarters
Korea South Seoul, Korea South
Employees
8 11 larger
Industry
Biotechnology, Pharmaceutical Not tracked yet
Funding Stage
Seed Series A
Total Funding
Not tracked yet $15.00M
Funding Rounds
3 1
Services
Not tracked yet Gene Therapy Development, Research and Development, Contract Development and Manufacturing, Platform Technology Solutions, Biomedical Research
Target Customers
Not tracked yet Pharmaceutical Companies, Biotechnology Firms, Healthcare Providers, Research Institutions, Patients with Chronic Illnesses
Taxonomy
Cell Biology, Neuroscience, Drug Development, Cell Therapy, Somatic Cell Reprogramming, Regenerative Medicine Oncolytic Virotherapy, Adenovirus Platform, Viral Immunotherapy, Cancer Therapeutics, Gene And Cell Therapy, Intratumoral Administration, Systemic Delivery Platform, Tumor-Targeted Therapies, Immunogenic Cell Death, Immune Checkpoint Inhibitors, Advanced Cancer Treatment, Antitumor Immune Activation, Biomedical Engineering, Genetic Engineering, Synergistic Combination Therapy
Website
cellapeuticsbio.com gene-medicine.com
Cellapeutics bio logo

About Cellapeutics bio

Cellapeutics Bio, with the slogan "Global standard of cell reprogramming platform," is a bio-venture company founded in 2020. The company operates in the Biotechnology and Pharmaceutical industries, with its headquarters located in Korea South. Cellapeutics Bio specializes in developing cell therapy...

GeneMedicine logo

About GeneMedicine

GeneMedicine is a biopharmaceutical company established in 2014 and headquartered in Korea South, positioned at the forefront of viral immunotherapy for cancer treatment. Specializing in R&D and commercialization of an advanced oncolytic adenovirus platform, the startup is creating groundbreaking th...

Be first to know when either one moves

Funding rounds, hiring surges, leadership changes and stack switches at Cellapeutics bio and GeneMedicine — tracked continuously, sent the day they land.

Watch both — free

Funding, hiring, leadership and stack changes at Cellapeutics bio and GeneMedicine — by email.

Frequently Asked Questions

Cellapeutics bio — Global standard of cell reprogramming platform. GeneMedicine — Biopharmaceutical company focusing on R&D and commercializing its oncolytic adenovirus platform for cancer treatment.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Cellapeutics bio has raised undisclosed funding while GeneMedicine has raised $15.00M.
Cellapeutics bio and GeneMedicine operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Cellapeutics bio with someone else

Start typing a company name or domain.

One analytics cookie (Google Analytics). Cookie Policy